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TLR4 SIGNALING NEGATIVE MODULATORS – CLATHRIN AND 
CAVEOLIN AS POTENTIAL THERAPEUTICS IN ENDOTOXIN-RELATED 
INFLAMMATION IN IMMATURE ENTEROCYTES 
KATHRYN MANALO 
ABSTRACT 
Microbe-induced TLR4 trafficking is needed to promote innate immunity and an 
inflammatory reaction. We showed that increased TLR4 expression in immature 
enterocytes is associated with severe inflammation and the development of necrotizing 
enterocolitis (NEC). Thus, we need to determine the intracellular regulatory mechanisms 
for TLR4 trafficking in fetal enteric inflammation. Here, we show that both clathrin- and 
caveolin-dependent endocytosis are necessary for the prevention of the fetal colonic 
(FHC) IL-1β response to endotoxin (LPS, a TLR4 agonist). In response to LPS 
stimulation, the inhibitor of clathrin, chlorpromazine (CPZ), and caveolin 1, Methyl-β-
cyclodextrin (MβCD), significantly increased TLR4 mRNA and surface protein 
expression by retaining TLR4 in the early endosome. An increased TLR4 resulted in 
increased proinflammatory cytokine IL-1β mRNA and protein induction in a time 
dependent manner. TICAM2, elicited by TLR4, mediates down-stream TLR4 signaling. 
MβCD did not increase TICAM2 mRNA expression indicating that CPZ and MβCD 
affect TLR4 signaling differently. In addition, both CPZ or MβCD alone and CPZ or 
MβCD plus LPS reduced IL-10 mRNA expression, which functions to reduce LPS IL-1β. 
Collectively, these data identify an additional role for intestinal expression of clathrin and 
caveolin in anti-inflammation via gram negative pathogen LPS through regulation of 
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TLR4 trafficking and cytokine expression in immature enterocytes. Study of the 
endocytosis pathway is likely to lead to successful strategies for prevention, treatment 
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Interest in the human gut microbiome has grown considerably in the past decade 
due to its implication in overall individual health. Evidence of this growth can be seen in 
the establishment of the Human Microbiome Project (HMP). In 2009, the National 
Institute of Health founded this project as a result of the growing body of knowledge of 
the microbiome. The goals of the project are to characterize a “normal”, healthy 
microbiome, determine potential connections between the microbiome and diseases, and 
to provide a standardized data source for all things related to the microbiome. The 
microbiome is present where microorganisms establish colonies such as the mouth, gut, 
vagina, and skin (Peterson et al., 2009). Under normal conditions, the host and bacteria, 
in particular, have a symbiotic relationship that promotes positive overall health. These 
bacteria have important roles in nutrient metabolism, drug metabolism, recognition of 
harmful pathogens, and protection of the intestinal barrier function (Jandhyala et al., 
2015).  
 The difficulty of characterizing a “normal” microbiome lies in the fact that the gut 
microbiome differs from person to person and therefore, a single characterization of the 
gut microbiome cannot be applicable to multiple persons (Peterson et al., 2009). Instead, 
researchers have observed that gut microbiomes with a high diversity of bacteria are 
more likely to have positive overall health. Alpha diversity refers to the diversity of 
bacteria within the same species and beta diversity refers to the diversity of bacteria 
between species. The alpha and beta diversity are related to the number of bacterial genes 
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present in the gut. Individuals with a high gene count (HGC) and thus, a more diverse gut 
microbiome, have been found to have lower incidences of metabolic diseases and obesity 
compared to those individuals with low gene count (LGC) (Jandhyala et al., 2015).  
Among the over 35,000 bacterial species present in the gut microbiome, 
researchers have observed Firmicutes and Bacteriodetes to be two bacterial phyla that 
predominate the microbiome. In addition to the observation, researchers have also 
observed spatial and temporal differences along the intestines. Figure 1 shows a summary 
of the most common bacterial colonies present in various locations along the intestine 
(Jandhyala et al., 2015). 
 
 




These strains in particular produce short chain fatty acids (SCFAs) from bacterial 
fermentation and play an important role in maintaining the symbiotic relationship 
between the bacterial colonies and host (Fabbiano, Suárez-Zamorano, & Trajkovski, 
2017).  
 The characterization of the gut microbiome is important because of the potential 
effects on overall health. The United States is well known for having high incidences of 
obesity, allergies, hypertension, and heart disease to name a few (Thornburn, Laurence, 
& Mackay, 2014). With the increasing knowledge of the gut microbiome, researchers 
have begun investigating how gut dysbiosis may be a factor in these life-threatening 
diseases common in the American population. Persistent dysbiosis within the gut 
describes the loss of traditional bacterial phyla and an increase in pathogenic bacteria An 
important thing to note is that these life-threatening diseases are a result of persistent 
dysbiosis. An assault on the gut that leads to a temporary imbalance between the 
beneficial and pathogenic bacteria and returns to normal is a healthy mechanism. (Round 
& Mazmanian, 2009). While the microbiome has not been proven to cause obesity in 
humans, there has been a causal link between obesity and the microbiota in mice. Gut 
microbiota transfer from obese mice to germ free non-obese mice resulted in weight gain 
of the previously non-obese mice (Ridaura et al. 2013). Potential explanations for obesity 
in humans include increasing fatty acid storage in adipocytes, reducing ghrelin levels that 
prevents the body from recognizing satiety, and increasing triglyceride synthesis in the 
liver (Isoluari, 2017). Metabolic endotoxemia is the threefold increase in 
lipopolysaccharide (LPS) serum concentration in the blood and is another result of a 
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dysbiotic state. Individuals with metabolic endoxtemia can suffer from inflammation, 
adipose tissue fibrosis, decreased thermogenesis, and altered glucose metabolism 
(Fabbiano, Suárez-Zamorano, & Trajkovski, 2017). Other dysbiotic microbiotic states 
affect Type 2 diabetes (Ley et al., 2005), non-alcoholic fatty acid disease (Dumas et al., 
2006), and chronic kidney disease (Lau & Vaziri, 2017).  
With the increasing information about the gut microbiota effects on overall health, 
modulation of the gut microbiota as a potential thereapeutic tool is a reasonable area of 
interest for researchers. The microbiota has been shown to be modulated by numerous 
genetic and environmental factors including antibiotic use, probiotics and diet. Probiotics 
are viable microorganisms that are generally found in dairy products or supplements that 
have the potential to be beneficial to individuals (Jandhyala et al., 2015). They have been 
found to protect against irritable bowel syndrome, ulcerative colitis, allergic diseases, and 
obesity (Fabbiano, Suárez-Zamorano, & Trajkovski, 2017).  
While probiotic mechanisms of action are not fully understood, they modulate the 
microbiota via inhibition of the T-cell mediated inflammation, increase in anti-
inflammatory cytokines, decrease in pro-inflammatory cytokines, enhancing intestinal 
barrier function, and modulation of intracellular signaling cascades. Figure 2 summarizes 






Figure 2: Effect of probiotics in various locations (Llewewllyn & Foey, 2017) 
As shown in Figure 2, the actions and effects of specific bacterial probiotics are 
multifaceted in nature and can aid in the reduction of inflammation. For example, the 
encircled area in Figure 2 shows a simplistic interpretation of the inflammatory response. 
A probiotic such as the Lactobacillus strain, Lca, is shown to prevent inflammation. 
These observations provide significant evidence for the protective function of probiotics 
on the gut microbiota. 
 Diet is another significant factor that aids in modulation of the gut microbiota. In 
the United States, people generally follow the “Western Diet”. The Western Diet is 
composed of high trans- and saturated fat, high sugar, and low fiber containing foods 
(David et al., 2014). Contrary to the Western diet is the Mediterranean diet, which 
contains high monounsaturated and polyunsaturated fats, vegetables, fibers, and low 
dairy and red meat products (Singh et al., 2017). The Western diet has been linked to 
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adverse health outcomes such as hypertension, high cholesterol, obesity, and Type 2 
diabetes. Based on previous studies, researchers sought to understand why these health 
outcomes were prevalent in the United States, but not in other countries with a much 
different diet.  
David et al. (2014) investigated the differences between these diets by looking at 
the extremes: a solely animal based diet versus a solely plant based diet. The animal 
based diet saw a 37% increase in dietary fat, 13.8% increase in dietary protein, and 9.3% 
decrease to nearly zero levels of fiber. The plant based diet on the other hand resulted in a 
16.3% increase in fiber, 10.4% decrease in fat, and 5.8% decrease in protein. The change 
in the diet led to a rapid change in the gut microbiota composition. Those that had the 
high fat intake showed increased levels of deoxycholic, which is a bile acid that has been 
shown to lead to liver cancer, in their fecal samples. The phyla Bacteriodetes and 
Firmicutes, which usually predominate in the normal microbiota, were found to be 
inhibited by the animal based diet. Instead, there was an increase in B. wadsworthia, 
which has been linked to inflammatory bowel disease. Those that had the plant based diet 
had minimal adverse changes in their microbiota. Because of the increase in carbohydrate 
fermentation from the plant based diet, there was an increase in SCFAs, leading to anti-
inflammatory effects (David et al., 2014).  
 A diet containing the proper amounts of protein, fat, and carbohydrates is 
important in proper nutrition. However, the sources of these macronutrients is also 
important to consider. Protein is generally found in meat products, but can also be found 
in legumes and nuts. As reported by Singh et al. 2017, meat products increased bile-
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tolerant anaerobes that do not rely on oxygen to exist. This resulted in more weight loss, 
but could also lead to detrimental health effects. Diets rich in animal products decreased 
levels of butyrate and Roseburia, which is characteristic of patients with irritable bowel 
disease. In mouse models, there was an increase in insulin-like growth factor (IGF-1), a 
hormone that regulates growth hormone. An increase in IGF-1 can lead to cancer and 
diabetes. In contrast, diets rich in plant based protein had the opposite effects including 
lower mortality than animal derived protein diet(Singh et al., 2017). 
 Lipids are also important for proper nutrition, but the type of lipid determines the 
effect on the gut microbiota. Lipids come in two flavors: “unhealthy” and “healthy”. The 
unhealthy lipids are trans- and saturated fats. These lipids are considered unhealthy 
because they are associated with increasing cholesterol and blood pressure.  At the gut 
microbiota level, these unhealthy lipids increase F. prausnitizii, which results in 
increased adipose tissue inflammation. These types of lipids are mainly found in the 
Western diet and help to explain the various adverse health outcomes in the United 
States. In contrast, the healthy lipids are monounsaturated and polyunsaturated fats. 
These lipids are considered healthy because they decrease cholesterol and fasting glucose 
levels. At the gut microbiota level, these healthy lipids increase Bifidobacterium and 
reduces pathogenic bacterial load, resulting in decreased inflammation (Singh et al., 
2017). 
 Similar to both protein and fats, the various type of carbohydrates consumed can 
cause different effects. Refined sugars are especially malnutritious because they spike 
blood glucose levels and can lead to an increase in glucose intolerance, obesity, and Type 
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2 diabetes. Carbohydrate sources rich in fiber and polyphenols are advantageous for a 
healthy gut. Fiber can be considered a prebiotic because it is a non-digestible dietary 
component that simulates the activity of beneficial microogranisms in the gut such as 
Bifidobacteria. Fiber, in particular, reduces the production of the pro-inflammatory IL-6, 
insulin resistance, cholesterol, low density lipoprotein (LDL), triglycerides, and increases 
the  anti-inflammatory cytokine, IL-10. Polyphenols are found in fruits, seeds, vegetables, 
tea, and wine and have antioxidant properties to neutralized reactive oxidative species in 
the gut (Singh et al., 2017). 
 Fiber is also advantageous for a healthy gut microbiota because consumption of 
fiber results in the production of SCFAs by resident bacteria. SCFAs provide several 
mechanisms which confer protection against the microbiota and the intestinal epithelial 
cells. The presence of SCFAs prevents pathogenic bacteria from interacting with the 
intestinal cells through competitive exclusion as shown in Figure 3. SCFAs also promote 




Figure 3. Short chain fatty acid mechanism of action within intestinal epithelial cells 
(Thorburn, Laurence, & Mackay, 2014).  
 
SCFAs can act on goblet cells directly and they also stimulate the Nod-like receptor 
pyrin-6 (NALP6) to produce mucus via G-protein coupled protein receptors (GCPRs). 
IgA is an antibody that is important for the production of mucous during an immune 
response. SCFAs also promote the secretion of IgA (Thornburn, Laurence, & Mackay, 
(2014). They also upregulate Treg cell cytokines, which promote immunological 
tolerance to food antigens. Lastly, they inhibit the NFkB pathway, which ultimately 
decrease the expression of inflammatory chemokines and cytokines (LLewewllyn & 
Foey, 2017). The numerous ways in which SCFAs confers protection upon gut 
microbiota and intestinal epithelial cells provides strong evidence for the importance of 
dietary fiber in maintaining a healthy gut. 
 
The Microbiome in Infants 
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The beginning of life is a crucial time for the establishment of the microbiome 
and has implications for the future health of the infant. The initial exposure to an 
extrauterine environment occurs upon delivery. Vaginally born infants are exposed to 
maternal bacteria and tend to have favorable outcomes. The microbial profile of vaginally 
born infants are generally predominated by Bacteriodes and Firmicutes (Rautava, 2017). 
Cesarean born infants, on the other hand, are first exposed to individuals that delivered 
them and the hospital environment. These infants tend to have unfavorable outcomes that 
can lead to intestinal dysbiosis. The long term implications of intestinal dysbiosis can 
result in asthma, food allergies, Type 1diabetes, and obesity later in life. The gut 
microbiota profile of cesarean born infants differs from vaginally born infants 
(Yamashiro, 2017). In the gut microbiota of cesarean born infants, researchers have 
observed a lower population of Bacteriodes and Firmicutes, and a higher population of 
pathogenic bacteria such as Proteobacteria (Walker, 2017). Additionally, the lack of 
transfer of maternal vaginal microbiota to cesarean section born infants did not result in 
an increase in Bacteriodes and Firmicutes. This suggests that the gut microbiota may be 
influenced by physiological conditions rather than microbiota prescence (Sakwinska et al. 
2017). Despite these observations, the rate of cesarean sections performed is rising in the 
United States. The World Health Organization recommends that cesarean sections should 
only be performed in emergencies and not exceed 10-15% of deliveries (Magne et al., 
2017). In the United States, the number of cesarean section procedures performed far 
exceeds the WHO recommendation (32.8%), making the health of infants into a public 
health concern (Betrán et al., 2016). 
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 Along with mode of delivery, the gut microbiota of infants is also influenced by 
maternal breast milk (MBM), antibiotic use, and gestational age. MBM contains 
oligosaccharides, which are broken down by bacteria to produce SCFAs that are 
beneficial to the gut microbiota (Chua et al, 2017). MBM is also considered to have its 
own “milk microbiome” that contains multiple beneficial bacterial species and IgA, 
which is important in the protection against pathogens (Gregory et al., 2016). Maternal 
antibiotic use is not advised due to the potential to cause intestinal dysbiosis (Kuperman 
& Koren, 2016). Gestational age is also a factor in the contribution to the gut microbiome 
composition. Research has shown that there is an inverse correlation between gestational 
age and diversity of the microbiome (Yasmin et al. 2017). 
 The total effect of these factors on the establishment of the infant gut microbiota 
are all interrelated. Yasmin et al. (2017) studied the combined effect of these factors on 
the gut microbiota. Ideally, infants are born vaginally, breastfed, and are not exposed to 
any maternal antibiotic use all of which increases the number of bacterial lactate 
producers and utilizers of SCFAs. In contrast, infants born via cesarean section, exposure 
to maternal antibiotic use and are formula-fed are more likely to be dysbiotic and have an 
increase in pathogenic bacteria. Research has also shown the combined effects of 
gestational age and MBM on the composition of infant gut microbiota. Infants fed with 
MBM all had similar microbiome compositions, whereas infants fed with formula tended 
to vary in their gut microbiota composition. Additionally, researchers found that 
pasteurized donor human milk is sufficient to replace MBM if the infant was born after 
28 weeks (Gregory et al. 2016). Another interesting perspective to take note of is the 
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change in MBM composition during the different types of delivery. Toscano et al. (2017) 
sought to establish these observations. Mothers that had undergone a vaginal delivery 
showed an increase in bacterial diversity of their MBM. Mothers that had undergone a 
cesarean section showed an increase in pathogenic bacteria, such as Haemophilus, and 
bacteria that can lead to skin and tissue infections (Toscano et al., 2017). Establishment 
of the gut microbiota begins in the womb and is affected by a variety of factors, all of 
which influence the composition of the initial colonizing gut microbiota and thus, all 
have a role in long-term health outcomes. 
 
Necrotizing Enterocolitis 
The leading cause of death among premature infants is necrotizing enterocolitis 
(NEC).   This disease affects as many as 15% of premature infants weighing less than 
1500g, of which up to 30% of infants will not survive. Additionally, infants that require 
surgical intervention have a mortality rate of 50% (Gregory et al. 2011). NEC treatment 
alone accounts for 19% of neonatal expenditures and requires five billion dollars per year 
for hospitalizations. Parents with a NEC baby can expect to pay almost up to $200,000 to 
treat their infants (Gephart et al. 2012). Despite the high mortality rates and cost of NEC, 
the pathogenesis is still poorly understood. Prenatal risk factors include maternal 
antibiotic use, maternal hypertensive disease, maternal infections, and placental blood 
flow restrictions. Intrapartum risk factors include maternal cardiac arrest and 
chorioamnioitis. However, the only constant independent predictors of developing NEC 
are prematurity and formula feeding (Samuels et al. 2017).  
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 The current understanding of NEC pathogenesis begins with the premature 
intestine and an innate immune response. The tendency of inflammation is greater than 
the inhibition of inflammation in patients with NEC. The premature intestine interferes 
with normal intestinal tract function such as motility and nutrient absorption. When these 
functions are compromised, the intestines are more likely to be exposed to harmful 
substances and cannot absorb adequate nutrition, and increases the chance of developing 
NEC. Once the intestinal integrity is compromised, a number of conditions can result 
such as hypoxia, hypoperfusion, and aberrant colonization (Patole, 2017). The physical 
manifestations have been categorized according to the severity of the disease. The Bell 
Stages were created in the 1978 and have since been used as the standard in staging NEC. 
Stage I, suspected NEC, is characterized by temperature instability, lethargy, apnea, 
bradycardia, poor feeding, vomit, mildly distended abdomen, and stool with occult blood. 
Stage II, proven NEC, is characterized by marked abdominal distension and persistent 
blood in stool. Stage III, advanced NEC, is characterized by deterioration of vital signs, 
septic shock, GI bleeding, and bowel necrosis. Additionally, lab values suggest metabolic 
acidosis, thrombocytopenia, neutropenia, disseminated intravascular coagulation. 
Physical signs include absent bowel sounds, and abdominal tenderness as other 
determinants of NEC (Gregory et al. 2011).  
  Feeding the infant with its mother’s breast milk and vaginal delivery are ideal 
conditions in order to prevent NEC. In cases where NEC has already occurred, the main 
treatment is a careful balance of feeding the infant with the correct amount of human 
breast milk in order to avoid agitating the fragile intestines of infants. Human breast milk 
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is beneficial to the infant’s growth and development because it contains probiotics, 
beneficial bacteria and stimulates the production of oligosaccharides (Gregory et al. 
2016). Other treatments of NEC include bowel rest, gastric decompression, hydration, 
perfusion, and surgical interventions (Lee & Polin, 2003). 
 
Endocytic Mechanisms of Inflammation 
  A potential factor in the development of NEC could be caused by the immature 
endocytotic mechanisms to cause inflammation. Lipopolysaccharides (LPS) are produced 
by gram negative bacteria found within the intestines. The innate immune response 
begins with a stimulus such as LPS and the activation of pattern recognition receptors 
(PRRs) such as toll-like receptors (TLR). The complex of LPS-TLR4 on the enterocyte 
surface must be endocytosed in order to stimulate inflammation. Upon internalization of 
the TLR4-LPS complex, the innate immune response continues through various 
intracellular downstream pathways and ultimately leads to the production of 
proinflammatory cytokines such as IL-1β. After the initial inflammatory response, the 
body produces antigens that are important in the adaptive immune response. When the 
body is exposed to the same type of the stimulus thereafter, the antigens produced in the 
innate immune response are used and results in faster resolution of the inflammation. 
Figure 4 shows a brief overview of the innate immune system and its interaction with the 




Figure 4. The innate and adaptive immune systems and their interactions (Gregersen & 
Behrens, 2006.) 
 
In mature enterocytes, the amount of TLR4 at the surface of the cell is 
significantly lower than the amount of TLR4 present at the surface of immature 
enterocytes (Meng et al. 2015).  Downstream signaling of TLR4 only occurs upon 
internalization via clathrin dependent or caveolin dependent pathways. Clathrin and 
caveolin are membrane proteins  that are responsible for the formation of calthrin- or 
caveolin-coated vesicles. These vesicles are important in the internalization of TLR4 and 
subsequent endocytosis. In mature cells, clathrin has been shown to be more important 
and in immature cells, caveolin has been shown to be more important to the 





Figure 5: TLR4 downstream signaling (Bagchi et al. 2007) 
TLR4 signaling continues with either an MyD88 dependent pathway or an 
MyD88 independent pathway (Fig. 5). TLR4 is sent to an early endosome where the 
receptor is destined for degradation via ubiqutination. The MyD88 dependent pathway 
stimulates the transcription factor, NF-kB, to initate inflammatory gene transcription 
within the nucleus (Gregory et al., 2016). For the purposes of our research, the production 
of the proinflammatory cytokines such as IL-1β through the MyD88 dependent pathway 
is the indication that inflammation has occurred (Bagchi et al. 2007).  
 
Purpose of this Research 
 Necrotizing enterocolitis is a devastating disease that affects premature infants, 
yet little is known about the disease. The impact of nutrition on the infant microbiota 
development as well as the initial colonization of the intestine are areas of investigation 
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to understand NEC. More importantly, the mechanism underlying abberant and persistent 
inflammation within the immature intestine is poorly understood.  A potential factor in 
the development of NEC and the principle area of investigation for this research is the 
possibility of abnormal endocytosis in immature intestinal cells. While the intracellular 
mechanisms of TLR4 in adult intestinal cells are well characterized, the intracellular 
mechanisms of TLR4 signaling transduction after LPS stimulation are still incomplete. 
We hypothesize that abnormal immature endocytosis is responsible for the production of 
proinflammatory cytokines, specifically IL-1β and excessive inflammation for the 









Cell lines were obtained and cultured from fetal human colonic (FHC) tissue and adult 
normal colon mucosa (NCM) tissue. LPS was used to stimulate an immune response in 
both FHC and NCM cell lines. Chloropromazine (CPZ) and Methyl-β-cylodextrin 
(MβCD) are both inhibitors of endocytosis and inhibit clathrin and caveolin respectively.  
 
Cell Culture 
FHC cells were grown in FHC media within a 1L flask. The media was replenished three 
days after the initial passage and the cells grew until confluence. The cells were 
incubated at 37°C. NCM cells followed a similar protocol, but were nourished with NDM 
media supplemented with serum.  
 
Cell stimulation  
Both FHC and NCM cell lines were subjected to the same stimulation. All cells were 
transfered in a 12-well plate and pretreated with CPZ or MβCD for 30 minutes. After 30 
minutes, cells were treated LPS for 5 minutes, 45 minutes, 6 hours, or 24 hours. The 
control group received no pretreatment with CPZ or MβCD, nor treatment with LPS. 






Materials from the RNeasy Mini Kit from Qiagen were used to perform RNA 
isolation. The 12-well plates were washed with PBS and then immediately treated with 
1mL of TRIzol. The samples were collected and placed in RNase free tubes and 0.2 mL 
choloform was added. After 10 minutes at room temperature, the samples were 
centrifuged for 15 minutes at 14,000 RPM. The upper, clear part of the tubes were 
collected and placed into new tubes. The samples were then treated with 0.5 mL 
isopropanol and placed on dry ice for 1 hour. After an hour, the samples were removed 
from the dry ice and returned to room temperature. The cells were centrifuged at 14,000 
RPM for 10 minutes. The supernatant was removed and the remaining pellets were 
treated with 1 mL of 75% ethanol. The samples were centrifuged for 10 minutes at 
14,000 RPM. After the supernatant was removed, the samples were air dried for 10 
minutes and dissolved in 20 µL of DEPC H2O. The samples were measured using 
NanoDrop to calculate the final RNA concentration. 
 
Reverse Transcriptase PCR (RT-PCR) 
Materials from Takara Clontech were used to perform RT-PCR. Using the RNA 
concentration from RNA isolation, the appropriate volume of RNA was calculated to 
obtain 200ng of RNA. This amount of RNA was then dissolved in the appropriate 
volume of DEPC H2O so that the resulting sample was 12.5 µL total. Each of the samples 
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were placed in heat-resistant tubes. The samples were treated with 1.0 µL of a random 
hexamer and subjected to 70°C for 2 minutes and then immediately placed on ice. A 
mixture containing 4.0 µL of 5x reaction buffer, 1.0 µL dNTP, 0.5 µL recombinant 
RNase inhibitor, and 0.5 µL MMLV reverse transcriptase were added to each sample that 
resulted in a 20 µL sample. The samples were placed in the BioRad © RT-PCR machine 
and resulted in newly formed cDNA. 
 
Real Time-PCR 
Real time-PCR was performed to quantify mRNA expression of certain biomarkers such 
as IL-1β, IL-10, caveolin, and clathrin. A 96-well real-time PCR plate was used and 
GAPDH was used as a standard. Each well contained 1.0 µL sample, 1.0 µL primer, 8.0 
µL DEPC H2O, and 10.0 µL SYMBR-green. The plate was placed in an Applied 
Biosystems real-time PCR machine and mRNA expression was calculated. 
 
Image Analysis 
The supernatant obtained from the cell stimulation methods were used to prepare slides 
for staining. Fluorescent dyes FITC and GFP were used to stain TLR4 and early 
endosomes (EEA1), respectively. Slides were analyzed using a confocal microscope. The 
images were analyzed using ImageJ software. The corrected total cell fluorescence 
(CTFC) measures the discreet fluorescence of TLR4 or EEA1. The CTFC was calculated 




Integrated density – (area of selected cell x mean fluorescence of background reading) 
= CTFC 
 




Both CPZ and MβCD accelerate IL-1β mRNA expression in immature FHC cells. 
When clathrin and caveolin are inhibited by CPZ and MβCD respectively, IL-1β 
mRNA expression increases under both conditions. In FHC cells pretreated with CPZ, 
IL-1β mRNA expression increased and reached a maximum at t=45 minutes (Fig. 7A). In 
FHC cells pretreated with MβCD, IL-1β mRNA expression was significantly higher at all 
time points, despite having a decreasing trend (Fig. 7b). MβCD showed a continued 




Figure 7: The effect of pretreatment and stimulation on IL-1β mRNA expression. FHC 
cells pretreated with CPZ and stimulated with LPS caused an initial increase in IL-1β 
mRNA expression (a). FHC cells pretreated with MβCD and stimulated with LPS caused 
an increase in IL-1β mRNA expression (b). FHC cells only stimulated with LPS 





































































































































































LPS could not increase IL-1β mRNA expression in mature NCM cells 
 Over a six hour period, pretreatment with CPZ did not increase IL-1b mRNA 
expression levels despite a significantly higher IL-1 mRNA expression level at t=45 
minutes (Fig. 8a). 
 Pretreatment wit MβCD increase IL-1β mRNA expression levels at t=45 minutes 
and t=6 hours as compared to cells only stimulated with LPS (Fig. 8b).  
 
Figure 8: The effect of CPZ and MβCD on IL-1β mRNA expression in NCM cells. 
NCM cells pretreated with CPZ did no increase IL-1β mRNA expression (a). NCM cells 








































































































Both CPZ and MβCD increased TLR4 mRNA expression in FHC cells. 
 
 Cells only stimulated with LPS, pretreated with CPZ and stimulated with LPS, 
and pretreated with MβCD and stimulated with LPS all showed an increase in TLR4 
mRNA expression as compared to the control. Cells pretreated with MβCD and 
stimulated with LPS showed a significantly higher TLR4 mRNA expression as compared 
to all other conditions (Fig. 9).   
 
Figure 9: The effect of pretreatment and LPS stimulation on TLR4 mRNA expression. 
Stimulation of FHC cells with LPS and pretreatment with CPZ and MβCD increased 
































































The effect of CPZ or MβCD on NCM cells had no effect on TLR4 mRNA expression. 
 
 There was no significant difference in TLR4 mRNA expression levels in NCM 
cells pretreated with CPZ versus NCM cells only stimulated with LPS (Fig. 10a). 
 There was no significant difference in TLR4 mRNA expression in NCM cells 
pretreated with MβCD versus NCM cells only stimulated with LPS (Fig. 10b). 
 
Figure 10: The effect of CPZ and MβCD on TLR4 mRNA expression in NCM cells. 
CPZ pretreatment did not increase TLR4 mRNA expression in NCM cells (a). MβCD 










































































































CPZ and MβCD retain TLR4 in the early endosome in immature cells. 
 
 FHC cells were stained with fluorescent dyes. TLR4 was stained red and EEA1 
(early endosome) stained green. The images show that TLR4 was retained in the early 
endosome for a longer period when FHC cells were pretreated with CPZ or MβCD (Fig. 
11). In cells that were only stimulated with LPS, there was no overlap of TLR4 with 
EEA1 (Fig. 11a). In cells pretreated with CPZ and then stimulated with LPS, there is 
visual evidence of EEA1 with TLR4 overlap beginning at t=5 minutes. The 
colocalization of TL4 and EEA1 becomes more evident as time goes on (Fig. 11b). In 
cells pretreated with MβCD, there is overlap of TLR4 and EEA1, however, not to the 
extent seen in CPZ pretreated cells (Fig. 11c).  
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Figure 11: Immunostaining of FHC cells. EEA1 stained with GFP  and TLR4 stained 







MβCD accelerated LPS induced TLR4 expression in FHC cells.  
 
 The corrected total cell fluorescence (CTFC) was calculated to give discreet 
values for the effects of CPZ and MβCD on TLR4 fluorescence respectively. After t=45 
minutes, FHC cells that were pretreated with MβCD and stimulated with LPS showed a 
significantly higher TLR4 CTFC than cells pretreated with CPZ and cells only stimulated 
with LPS. The group of FHC cells pretreated with CPZ and stimulated with LPS was the 
only group that did not significantly increase TLR4 CTFC (Fig. 12a.) At t=6 hours, all 
groups showed an increase in TLR4 CTFC.  (Fig. 12b).  
 
Figure 12: The corrected total fluorescence of TLR4. The corrected total cell 
fluorescence (CTCF) was calculated following the formula: CTCF=Integrated density-
(area of selected cell X the mean fluorescence of background reading). Cells pretreated 
with MβCD showed a significantly higher TLR4 CTFC at t=45 minutes (a). Similar 































































































































CPZ and MβCD decrease IL-10 mRNA expression in immature cells. 
 
 IL-10 has been shown to inhibit LPS induced IL-1β production in human 
monocytes. Information regarding IL-10 as an anti-inflammatory cytokine in the 
immature human enterocyte was previously unknown. In cells stimulated with LPS, LPS 
stimulation alone did not affect IL-10 mRNA expression (Fig. 13a). When FHC cells 
were pretreated with CPZ and then stimulated with LPS, there was a significant decrease 
in IL-10 mRNA expression (Fig. 13b). Pretreatment with MβCD and subsequent 






Figure 13: The effect of pretreatment and stimulation on IL-10 mRNA expression levels. 
There was no significant difference in IL-10 mRNA expression following LPS 
stimulation (a). IL-10 mRNA expression decreased following CPZ pretreatment and LPS 
stimulation (b). FHC cells pretreated with MβCD and stimulated with LPS decreased IL-










































































































































































Clathrin and Caveolin affect TLR4 signaling differently in immature cells. 
 
 As we saw earlier, clathrin and caveolin function at different times, however, we 
provide evidence that clathrin and caveolin affect the TLR4 mediated inflammatory 
pathway differently by observing TICAM2 mRNA expression. TICAM2 is an adaptor 
protein that is activated upon TLR4 activation. Pretreatment with CPZ was able to induce 
and increase in TICAM2 mRNA expression. The effects of CPZ were found as early as 
t=5 minutes. Even without LPS stimulation, TICAM2 mRNA expression was 
significantly increased from the other groups (Fig. 14a). The effects of CPZ continued for 
24 hours (Fig. 14b). FHC cells that were stimulated with LPS with or without MβCD 
pretreatment did not increase TICAM2 mRNA expression (Fig. 14a). Similar results for 




Figure 14: The effect of pretreatment and LPS stimulation on TICAM2 mRNA 
expression. After 6 hours, CPZ was able to increase TICAM2 mRNA expression, while 
LPS stimulation with or without MβCD pretreatment could not (a). After 24 hours, CPZ 
was still effective in increasing TICAM2 mRNA expression and LPS stimulation with or 














































































































 Necrotizing enterocolitis is the leading cause of death among premature infants. 
Previous research showed that an increase in TLR4 expression on immature cell surface 
resulted in severe inflammation and can lead to necrotizing enterocolitis. The intracellular 
mechanisms of TLR4 signaling in fetal enteric cells were previously incompletely 
understood. Our results show the importance of the endocytic mechanisms involving 
clathrin and caveolin in the prevention of fetal enteric inflammation. 
 An effect of TLR4 activation is the production of IL-1β via the NF-κB pathway 
and thus, IL-1β was used as a marker for inflammation. In FHC cells that were pretreated 
with CPZ or MβCD, IL-1β mRNA expression increased. FHC cells pretreated with CPZ 
showed an early response in IL-1β induction whereas MβCD showed a delayed response, 
indicating that clathrin and caveolin function in a time dependent manner. Additionally, 
this suggests that a delayed endocytosis of the LPS-TLR4 complex affected the 
inflammatory response. These results provide evidence for the importance of clathrin and 
caveolin in the regulation of the proinflammatory cytokine, IL-1β via activation of TLR4 
in immature FHC cells.  
Previous research suggested the implications TLR4 had in the immature immune 
response due to higher amounts of TLR4 at the surface in comparison to mature 
enterocytes.. When FHC cells were pretreated with CPZ or MβCD, TLR4 mRNA 
expression increased.  These results suggest the importance of clathrin and caveolin in 
regulating TLR4 induction. The effect of CPZ and MβCD on TLR4 in FHC cells was 
also observed using immunofluorescence and confocal microscopy. Compared to cells 
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only stimulated with LPS, FHC cells pretreated with CPZ and MβCD showed overlap of 
TLR4 and EEA1. We provide visual evidence that TLR4 is retained in the early 
endosome, and thus, is protected from degradation. From the images obtained by 
confocal microscopy, we  calculated the CTFC of TLR4. Our calculations confirmed that 
FHC cells pretreated with CPZ and MβCD increased the TLR4 CTFC. MβCD increased 
TLR4 CTFC to a greater extent than CPZ suggesting that caveolin has a stronger effect 
on immature endocytosis. These results in combination show that clathrin and caveolin 
are important for the degradation of TLR4 through endosomes. 
Interestingly enough, when these methods were applied to the mature NCM cells, 
the results were almost contradictory to those seen in immature FHC cells. NCM cells 
pretreated with CPZ or MβCD did not increase TLR4 mRNA expression or IL-1β mRNA 
expression. The mature nature of NCM cells could explain mechanisms found in these 
cells to respond to LPS stimulation more efficiently than the FHC cells.  
IL-10 is an anti-inflammatory cytokine that is known to regulate IL-1β levels. 
FHC cells that were pretreated with CPZ or MβCD showed a decrease in IL-10 mRNA 
expression. Along with regulating TLR4 levels, clathrin and caveolin also seem to 
encourage the production of IL-10 in the immature immune response as a way to regulate 
IL-1β induction.  
Both clathrin and caveolin are important in the immature immune response, yet 
act upon the TLR4 signaling pathway differently. Along the TLR4 signaling pathway is 
TICAM2, which is elicited by TLR4 activation. When FHC cells were pretreated with 
CPZ or MβCD, we observed that FHC cells pretreated with CPZ showed an increase in 
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TICAM2 mRNA expression. FHC cells pretreated with MβCD did not increase TICAM2 
mRNA expression. Although clathrin and caveolin have similar functions, we know that 
clathrin functions to regulate TLR4 via TICAM2, but MβCD does not. 
The mechanisms of immature inflammation is multifaceted and affects TLR4, IL-
10, and TICAM2 expression While our results have yielded novel data, many of our 
results are based on mRNA expression rather than protein expression. Future research 
should be directed towards understanding the mechanisms of TLR4, IL-10, and TICAM2 
on immature inflammation and determining protein expression to provide further 
evidence for the roles of clathrin and caveolin. Additionally, the specific effect of 
caveolin on TLR4 signaling should also be investigated. 
In summary, our results provide evidence that both clathrin and caveolin are 
important in immature endocytosis. Clathrin and caveolin are also important in the 
regulation of TLR4 during LPS stimulation, but have different mechanisms. Furthermore, 
our results suggest that LPS stimulation on TLR4 and is due to the high amount of TLR4 
at the surface of immature cells, which then leads to an increase in endocytosis and 
inflammation. Studies concerning the inflammatory response in immature cells should 
continue in order to prevent, treat, and improve outcomes of premature infants with 
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